ArticleNature communications2022

USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer.

Jessica K Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.